How does bone marrow suppression appear in lung cancer targeted therapy

summary

Once people have lung cancer, they need to go to a big hospital to treat it. Diet should also pay special attention, lung cancer is the most common primary lung cancer, the vast majority of lung cancer originated from bronchial mucosa epithelium, so also known as bronchial lung cancer. Over the past 50 years, countries all over the world, especially industrial developed countries, have encountered bone marrow suppression in lung cancer targeted therapy.

How does bone marrow suppression appear in lung cancer targeted therapy

First, lung cancer is the most common primary malignant tumor of the lung. Most lung cancer originates from bronchial mucosa epithelium, so it is also called bronchial lung cancer. In the past 50 years, the incidence rate and mortality of lung cancer in all countries, especially in developed countries, have increased rapidly. Lung cancer has ranked the top among male patients who died of cancer. More than 40 years ago, in China, the vast majority of patients who underwent surgical treatment for lung diseases were pulmonary tuberculosis, followed by bronchiectasis, lung abscess and other lung suppurative infections, and lung cancer cases were few.

Second: as long as the drug will have positive and negative effects. Unlike cytotoxic chemotherapy drugs, targeted drugs for lung cancer have obvious side effects such as gastrointestinal reactions, bone marrow suppression, epithelial shedding and hair loss. There are two main side effects of targeted drugs for lung cancer. One is the so-called skin rash reaction, and some are acne like manifestations. Another is mild diarrhea, some patients can not tolerate diarrhea and stop taking drugs.

Thirdly, the guidelines for the clinical diagnosis and treatment of adverse skin reactions of molecular targeted drugs for lung cancer in China have been formulated. Oncologists and dermatologists should summarize some principles for the treatment of side effects of molecular targeted drugs in the diagnosis and treatment of lung cancer.

matters needing attention

At present, chemotherapy is the main treatment for patients with advanced lung cancer. However, the main reason for the failure of chemotherapy is the resistance of lung cancer cells to anticancer drugs.